Active substance
Butorphanol
- US FDA 17
- Health Canada 1
- US price lines 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| BUTORPHANOL TARTRATE PRESERVATIVE FREE | 1MG/ML; 2MG/ML | injectable · injection | HOSPIRA | Prescription | 23 Jan 1997 |
| BUTORPHANOL TARTRATE PRESERVATIVE FREE | 1MG/ML; 2MG/ML | injectable · injection | HIKMA PHARMS | Prescription | 12 Aug 1998 |
| BUTORPHANOL TARTRATE | 2MG/ML | injectable · injection | HIKMA PHARMS | Prescription | 12 Aug 1998 |
| BUTORPHANOL TARTRATE | 1MG/SPRAY | spray, metered · nasal | HIKMA PHARMS | Prescription | 12 Mar 2002 |
| BUTORPHANOL TARTRATE | 1MG/SPRAY | spray, metered · nasal | APOTEX | Prescription | 4 Dec 2002 |
| BUTORPHANOL TARTRATE | 1MG/ML; 2MG/ML | injectable · injection | HIKMA FARMACEUTICA | Prescription | 1 May 2009 |
| STADOL PRESERVATIVE FREE | 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | APOTHECON | Discontinued | 22 Aug 1978 |
| STADOL | 2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | APOTHECON | Discontinued | 22 Aug 1978 |
| STADOL | 1MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | spray, metered · nasal | BRISTOL MYERS SQUIBB | Discontinued | 12 Dec 1991 |
| BUTORPHANOL TARTRATE PRESERVATIVE FREE | 1MG/ML; 2MG/ML | injectable · injection | HOSPIRA | Discontinued | 22 Jan 1997 |
| BUTORPHANOL TARTRATE PRESERVATIVE FREE | 1MG/ML; 2MG/ML | injectable · injection | HOSPIRA | Discontinued | 28 Sep 1998 |
| BUTORPHANOL TARTRATE | 1MG/ML; 2MG/ML | injectable · injection | HOSPIRA | Discontinued | 4 Nov 1999 |
| BUTORPHANOL TARTRATE | 1MG/ML; 2MG/ML | injectable · injection | HOSPIRA | Discontinued | 20 Mar 2000 |
| BUTORPHANOL TARTRATE | 1MG/SPRAY | spray, metered · nasal | RISING | Discontinued | 8 Aug 2001 |
| BUTORPHANOL TARTRATE PRESERVATIVE FREE | 1MG/ML; 2MG/ML | injectable · injection | BAXTER HLTHCARE CORP | Discontinued | 23 Oct 2001 |
| BUTORPHANOL TARTRATE | 2MG/ML | injectable · injection | BAXTER HLTHCARE CORP | Discontinued | 23 Oct 2001 |
| BUTORPHANOL TARTRATE | 2MG/ML | injectable · injection | HIKMA FARMACEUTICA | Discontinued | 29 Apr 2009 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| BUTORPHANOL NASAL SPRAY | 02242504 | 10 MG / ML | SOLUTION · NASAL | AA PHARMA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | BUTORPHANOL 10 MG/ML SPRAY | $15.45983 | per ML | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.